Episode Details
Back to Episodes
Inside Germany’s biotech capital infrastructure and innovation engine
Published 1 month, 2 weeks ago
Description
In this episode of Denatured, as part of our series of the European life science investment ecosystem, you'll be hearing from Regina Hodits, managing director at Angelini Ventures and Sofia Ioannidou, VC partner at Andera Life Sciences. They examine Germany’s biotech and life sciences landscape, focusing on the scientific, infrastructure and policy shifts required to enable European companies to scale globally while remaining anchored in Europe.
Host
Jennifer C. Smith-Parker, Director of Insights, BioSpace
Guests
Regina Hodits, Managing Director, Angelini Ventures
Sofia Ioannidou, VC Partner, Andera Life Sciences
Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.